Found 84 matching trials
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer PHASE2 The present investigation aims to evaluate the efficacy of an innovative pr...
Show More Location
Hôpital Antoine Béclère
Learn More & Join Trial
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer PHASE3 This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Show More Location
The Mayo Clinic - Phoenix
Learn More & Join Trial
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer PHASE2 Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Show More Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function NA Complaints about memory and thinking are common in women as they go through...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
ETHAN - ET for Male BC PHASE2 This research study is looking to see how well male breast cancer responds ...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial
Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer PHASE2 This was an open-label, multi-centre, uncontrolled, exploratory trial with ...
Show More Location
Urologische Praxis
Learn More & Join Trial
Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy PHASE2 The purpose of this study is to find out what effects, good and/or bad, tak...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer PHASE2 For this study, unfavorable intermediate risk prostate cancer patients will...
Show More Location
NYU Langone Health
Learn More & Join Trial
Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. PHASE2 The purpose of this study is to look at patient outcomes when docetaxel is ...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment NA The purpose of this study is to compare toxicities between 2 external beam ...
Show More Learn More & Join Trial